Research and Markets: New Born Screening Market Report 2014: Test Type, Technology, Instrument, Accessories, Reagent & Assay Kit Analysis
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/59dh72/newborn_screening) has announced the addition of the "NewBorn Screening Market by Test Type, Technology, Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019" report to their offering.
“NewBorn Screening Market by Test Type, Technology, Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019”
The global newborn screening market was valued at an estimated $438.9 million in 2013 and is expected to grow at a CAGR of 11.0% in the next five years.
This high growth is mainly attributed to the benefits offered by newborn screening programs, legislations and mandates, technological advancements, government support, and expanding panel of newborn diseases, and conferences and symposiums related to the usage of new technologies. Furthermore, various awareness programs and conferences are being organized across the globe, which is likely to drive the market growth. However, factors such as lack of trained professional infrastructure and socio-economic barriers are expected to hinder the market growth.
North America dominates the newborn screening market. Asia is poised to grow at the highest CAGR during the forecast period owing to support provided by foreign countries for enhancing screening services. Apart from this, factors such as increased government support and investment by major players in the region are expected to provide required impetus for the growth of this market.
This report categorizes the global newborn screening market on the basis of test type, technology, product, and geography. The mass spectrometry market is expected to register the highest growth rate in the newborn screening market by technology, during the forecast period. This high growth is attributed to various nations opting for expanded newborn screening. Tandem mass spectrometry is a fundamental instrument used for expanded newborn screening. Furthermore, various conferences and symposiums are being conducted to spread awareness for the use of such technologies. For instance, in May 2013, the Joint Meeting of the Newborn Screening and Genetic Testing Symposium was organized in Atlanta. The symposium was aimed to discuss national and international newborn screening, genetic testing, and policy issues.
Scope of the Report
By Test Type
- Dry Blood Spot Test
- Hearing Screen Test
- Critical Congenital Heart Disease (CCHD) Test
- Tandem Mass Spectrometry
- Enzymes and Immunoassays
- DNA-based Assays
- Hearing Screen Technology
- Pulse Oximetry Technology
- Newborn Disorder Screening Instruments
- Hearing Screening Instruments
- Hearing Screening Devices
- Hearing Screening Accessories
- Pulse Oximetry Instruments
- Reagents and Assay Kits
Key Topics Covered:
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Newborn Screening Market, By Test Type
6 Newborn Screening Market, By Technology
7 Newborn Screening Market, By Product Type
8 Newborn Screening Market, By Geography
9 Competitive Landscape
10 Company Profiles
- AB Sciex LLC (A Subsidiary of Danaher Corporation)
- Agilent Technologies Inc.
- Bio-Rad Laboratories, Inc.
- Covidien Plc
- GE Healthcare (Subsidiary of General Electric Company)
- Masimo Corporation
- Natus Medical Incorporated
- Perkinelmer, Inc.
- Trivitron Healthcare
- Waters Corporation
For more information visit http://www.researchandmarkets.com/research/59dh72/newborn_screening